ACS
LLY icon

Archford Capital Strategies’s Eli Lilly LLY Stock Holding History

Archford Capital Strategies’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.1M Buy
2,586
+95
+4% +$97.1K 0.31% 78
2026
Q1 		$2.29M Buy
2,491
+200
+9% +$203K 0.26% 87
2025
Q4 		$2.46M Sell
2,291
-15
-0.7% -$14.3K 0.29% 77
2025
Q3 		$1.76M Hold
2,306
– – 0.21% 105
2025
Q2 		$1.8M Sell
2,306
-141
-6% -$110K 0.23% 100
2025
Q1 		$2.02M Sell
2,447
-1,705
-41% -$1.42M 0.3% 93
2024
Q4 		$3.21M Buy
4,152
+68
+2% +$56.3K 0.48% 50
2024
Q3 		$3.8M Buy
4,084
+33
+0.8% +$29.7K 0.57% 46
2024
Q2 		$3.67M Sell
4,051
-220
-5% -$176K 0.59% 45
2024
Q1 		$3.32M Buy
4,271
+174
+4% +$124K 0.56% 48
2023
Q4 		$2.39M Sell
4,097
-467
-10% -$273K 0.44% 59
2023
Q3 		$2.45M Buy
4,564
+36
+0.8% +$18.6K 0.49% 52
2023
Q2 		$2.08M Buy
4,528
+132
+3% +$55.4K 0.39% 62
2023
Q1 		$1.59M Buy
4,396
+475
+12% +$160K 0.33% 69
2022
Q4 		$1.43M Buy
3,921
+502
+15% +$178K 0.33% 77
2022
Q3 		$1.11M Buy
3,419
+250
+8% +$79.2K 0.29% 88
2022
Q2 		$1.03M Buy
3,169
+219
+7% +$65.7K 0.26% 95
2022
Q1 		$863K Buy
2,950
+325
+12% +$83.6K 0.19% 133
2021
Q4 		$725K Buy
2,625
+63
+2% +$16K 0.17% 148
2021
Q3 		$592K Buy
2,562
+167
+7% +$41.2K 0.14% 171
2021
Q2 		$550K Buy
2,395
+58
+2% +$11.7K 0.14% 166
2021
Q1 		$434K Sell
2,337
-6,938
-75% -$1.36M 0.12% 189
2020
Q4 		$1.54M Sell
9,275
-25
-0.3% -$3.73K 0.35% 88
2020
Q3 		$1.38M Sell
9,300
-123
-1% -$19K 0.37% 81
2020
Q2 		$1.55M Sell
9,423
-41
-0.4% -$6.29K 0.46% 61
2020
Q1 		$1.31M Buy
9,464
+1,734
+22% +$238K 0.51% 59
2019
Q4 		$1.02M Hold
7,730
– – 0.35% 87
2019
Q3 		$864K Sell
7,730
-20
-0.3% -$2.23K 0.32% 96
2019
Q2 		$859K Sell
7,750
-55
-0.7% -$6.48K 0.31% 96
2019
Q1 		$1.01M Sell
7,805
-300
-4% -$36.5K 0.37% 82
2018
Q4 		$938K Sell
8,105
-30
-0.4% -$3.35K 0.38% 75
2018
Q3 		$873K Sell
8,135
-1,192
-13% -$119K 0.32% 90
2018
Q2 		$796K Buy
+9,327
New +$766K 0.28% 105
2018
Q1 		– Sell
-6,400
Closed -$541K – 692
2017
Q4 		$541K Sell
6,400
-1,676
-21% -$143K 0.2% 138
2017
Q3 		$690K Buy
8,076
+1,676
+26% +$137K 0.26% 128
2017
Q2 		$527K Sell
6,400
-2,421
-27% -$198K 0.21% 143
2017
Q1 		$755K Sell
8,821
-3,909
-31% -$313K 0.28% 118
2016
Q4 		$935K Buy
12,730
+4,456
+54% +$332K 0.39% 92
2016
Q3 		$663K Buy
8,274
+6,400
+342% +$512K 0.27% 123
2016
Q2 		$148K Sell
1,874
-4,526
-71% -$341K 0.08% 172
2016
Q1 		$461K Sell
6,400
-11,579
-64% -$876K 0.22% 133
2015
Q4 		$1.32M Buy
17,979
+13,029
+263% +$1.08M 0.6% 43
2015
Q3 		$414K Sell
4,950
-103
-2% -$8.7K 0.31% 80
2015
Q2 		$422K Sell
5,053
-1,115
-18% -$85K 0.3% 85
2015
Q1 		$448K Buy
6,168
+435
+8% +$31K 0.31% 87
2014
Q4 		$396K Sell
5,733
-31
-0.5% -$2.09K 0.29% 93
2014
Q3 		$374K Sell
5,764
-281
-5% -$17.8K 0.3% 97
2014
Q2 		$376K Buy
6,045
+4,818
+393% +$287K 0.29% 95
2014
Q1 		$72.2K Buy
+1,227
New +$68.5K 0.06% 179

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Archford Capital Strategies's LLY Position: Q2 2026 in Review

Archford Capital Strategies increased its Eli Lilly (LLY) stake by 3.8% in Q2 2026, buying an estimated $97.1K and bringing the position to 2,586 shares worth $3.1M. The position accounts for 0.31% of the portfolio, ranked #78.

Archford Capital Strategies first reported a position in LLY in Q1 2014 and has held it in 49 quarters since. The position peaked at $3.8M in Q3 2024. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Archford Capital Strategies held 2,586 shares of Eli Lilly worth $3.1M as of Q2 2026.
  • Archford Capital Strategies bought 95 Eli Lilly shares in Q2 2026, an estimated $97.1K.
  • Eli Lilly made up 0.31% of Archford Capital Strategies's portfolio in Q2 2026, its #78 holding.
  • Archford Capital Strategies first reported a position in Eli Lilly in Q1 2014 and has held it in 49 quarters since.
  • Archford Capital Strategies's Eli Lilly position peaked at $3.8M in Q3 2024.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Archford Capital Strategies's 13F filing for Q2 2026, filed 17 Jul 2026.